Release 5 Preview #2

This page is part of the FHIR Specification (v4.4.0: R5 Preview #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3 R2

4.3.15.477 HL7 Version 2 Table 0477

Vocabulary

Work Group

Maturity Level: N/A

External

Use Context: Any

This is a table defined as part of HL7 v2 .

Summary

Code System URL: http://terminology.hl7.org/CodeSystem/v2-0477

Value Set URL: http://terminology.hl7.org/ValueSet/v2-0477

Version: 2.9

Name: v2.0477

Title: v2 Controlled Substance Schedule

Definition:

FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)

OID: ??

CodeSystem Resource XML / JSON

ValueSet Resource XML / JSON

Note: V2 code systems may or may not be case sensitive. V2 Code systems will have the CodeSystem.caseSensitive correctly populated in a future version of this specification.

This value set is not currently used

4.3.15.477.1 Code System Content

Controlled Substance Schedule

Code

Description

Comment

Version

I

Schedule I

Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision.

added v2.5

II

Schedule II

Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability.

added v2.5

III

Schedule III

Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States.

added v2.5

IV

Schedule IV

Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States.

added v2.5

V

Schedule V

Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States.

added v2.5

VI

Schedule VI

State defined

added v2.5